- Prestige Estates reported a net income of 177 million rupees for the third quarter.
- This represents an 85% decrease year over year, missing the estimate of 2.21 billion rupees.
- Revenue for the quarter was 16.5 billion rupees, down 8.3% year over year and below the expected 24.5 billion rupees.
- Total costs amounted to 16.1 billion rupees, which is a decrease of 5.8% year over year.
- Other income declined significantly by 75% year over year, reaching 434 million rupees.
- Analyst recommendations include 16 buys, 0 holds, and 4 sells for Prestige Estates.
A look at Prestige Estates Projects Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts assessing Prestige Estates Projects using the Smartkarma Smart Scores have provided an overall outlook for the company. With respectable scores in Value, Resilience, and Momentum, Prestige Estates Projects is viewed favorably for its investment potential. The company’s dedication to delivering quality residential and commercial real estate projects, along with its ability to maintain stability and generate positive market traction, bodes well for its long-term prospects.
Prestige Estates Projects, known for its diverse real estate developments ranging from residential apartments to commercial office buildings and hotels, holds promise for investors seeking a blend of growth and stability. While the scores for Dividend and Growth are not as high, the company’s solid performance in key areas positions it well to navigate market challenges and capitalize on future opportunities in the real estate sector. Overall, Prestige Estates Projects appears to be a reputable player poised for sustained success in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
